Dr. Reddy’s launches Herceptin biosimilar in India 27-Jul-2018 By Flora Southey Dr. Reddy’s Laboratories has announced its biosimilar version of Roche’s Herceptin, Hervycta (trastuzumab), is now available on the Indian market.